Učitavanje...
Mitochondrial hyperactivity as a potential therapeutic target in Parkinson’s disease
Mitochondrial dysfunction is thought to contribute to neurodegeneration in Parkinson’s disease (PD), yet the cellular events that lead to mitochondrial disruption remain unclear. Post-mortem studies of PD patient brains and the use of complex I inhibitors to model the disease previously suggested a...
Spremljeno u:
| Izdano u: | Transl Med Aging |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7653964/ https://ncbi.nlm.nih.gov/pubmed/33178902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tma.2020.07.007 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|